Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,239.00
Bid: 2,238.00
Ask: 2,239.00
Change: 20.00 (0.90%)
Spread: 1.00 (0.045%)
Open: 2,222.00
High: 2,249.00
Low: 2,214.00
Prev. Close: 2,219.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

19 Mar 2020 07:00

RNS Number : 7077G
Halma PLC
19 March 2020
 

Halma today releases its scheduled trading update, for the period from 1 October 2019 to date.

 

The Group has made good progress during the period, although given the COVID-19 outbreak in the fourth quarter now expects adjusted profit before tax for the year ending 31 March 2020 to be in a range of approximately £265 million to £270 million. This compares to an average of current market forecasts of £275.5 million (see notes 1 and 2). Risks remain given the evolving and uncertain situation; the Board will continue to monitor the impact of the COVID-19 outbreak closely and take mitigating actions as appropriate.

 

The Group's financial position remains robust, with committed facilities totalling approximately £750 million (at current exchange rates), of which around 60% are drawn. The earliest maturity in these facilities is for £77 million (at current exchange rates) in January 2021, with the remaining maturities from 2023 onwards.

 

Order intake is currently ahead of revenue and ahead of the same period last year. We have continued to benefit in the period from the long-term growth drivers in our markets, the breadth of our portfolio and the resilience of our business model.

 

To date, the Group has delivered revenue growth in all four major regions and all sectors:

- The USA grew strongly and benefited from positive contributions from recent acquisitions. There was good growth in the UK and more moderate growth in Mainland Europe, while strong growth in Asia Pacific was driven by recent acquisitions.

 

- The Environmental & Analysis sector delivered strong organic growth in the period, with Infrastructure Safety delivering a strong performance, driven by positive contributions from recent acquisitions and solid organic growth. The Medical sector delivered solid revenue growth, although profit growth was lower. Although Process Safety's performance in the second half was affected by weaker oil and gas markets, the sector is expected to deliver a satisfactory performance for the full year.

 

The currency translation effect on the Group's results in the second half of the year is expected to be broadly neutral, resulting in a positive impact for the year ending 31 March 2020 as a whole (see note 3).

 

This has been a strong year for M&A activity, with ten acquisitions completed across all four sectors, for a total initial consideration of £227 million. We made seven acquisitions in the second half (see note 4 to this announcement, and our website www.halma.com). The integration of all acquisitions made during the year is currently progressing well.

 

The Group's next scheduled update on trading will be the announcement of its results for the year ending 31 March 2020, which will be released on 11 June 2020.

 

For further information, please contact:

 

Halma plc

Andrew Williams, Chief Executive

Switchboard: +44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor Relations

Mobile: +44 (0)7776 685948

 

MHP Communications

Rachel Hirst/ Andrew Jaques

+44 (0)20 3128 8100

 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner and healthier future for people worldwide. Our innovative products and solutions address many of the key issues facing the world today. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 6,000 people in more than 20 countries, with major operations in Europe, the USA and Asia-Pacific. We target global niche markets where sustainable growth and high returns are supported by long-term drivers. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes

 

1. Adjusted profit before tax is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and profit or loss on disposal of businesses.

 

2. The Board believes that current market forecasts for adjusted profit before tax for the year ending 31 March 2020 are in the range of £272.0 million to £278.3 million, with an average of £275.5 million.

 

3. Sterling has weakened in the financial year relative to many currencies, including the US Dollar and Euro and the currency translation impact on the Group's results for the financial year ending 31 March 2020 is expected to be positive. Based on the mix of currency denominated revenue and profit for the 2020 financial year, a 1% movement in the US Dollar changes full year revenue by £6.3 million and profit by £1.4 million. Similarly, a 1% movement in the Euro changes full year revenue by £1.6 million and profit by £0.3 million. The weighted average exchange rates relative to Sterling used to translate revenue and profit for the year ended 31 March 2019 were: US Dollar 1.31, Euro 1.14.

 

4. We made seven acquisitions in the second half of the current financial year.

 

In October 2019, we acquired the Trabectome and Goniotome product platforms from NeoMedix Inc., to enter the fast-growing minimally-invasive glaucoma surgery market. The initial cash consideration was US$8.1 million (£6.6 million) on a cash- and debt-free basis. Further earn-out considerations, capped at a total of US$17 million (£14.0 million) are payable in cash, dependent on performance in the three years to October 2022. In the same month, we also acquired Infowave Solutions Inc., a location sensing and software solutions provider, for CenTrak, to further expand its addressable market and enhance its technological and data capabilities. The initial consideration for Infowave was US$8.3 million (£6.8 million) with further earn-out considerations, payable in cash, of up to US$4 million (£3.3 million) in total, payable dependent on performance in each of the financial years ended March 2021 and March 2022.

 

In January 2020, we acquired NovaBone Products, LLC, a designer and manufacturer of US FDA-approved synthetic bone graft products, for US$97.0 million (£74.0 million). We also purchased a 70 per cent holding in FireMate Software Pty. Ltd, which provides cloud-based fire protection maintenance software to fire contractors, for an initial consideration of A$11.8 million (£6.2 million) and a further A$6.4 million (£3.3 million) contingent on performance to 30 June 2022. We have an option to purchase the remaining 30% of FireMate, exercisable in the six months from 31 March 2025.

 

In February 2020, we acquired Sensit Technologies, LLC, a gas leak detection company, for US$51.5 million (£39.6 million); Maxtec, LLC, a leader in the design, manufacture and distribution of oxygen analysis and delivery products, for US$20.0 million (£15.3 million); and Spreo, an indoor positioning and mapping platform company, to further enhance CenTrak's capabilities, for an initial consideration of US$0.6 million (£0.4 million) and contingent consideration of US$2.0 million (£1.5 million).

 

5. This Trading Update is based upon current management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks, including the effects of the current COVID-19 outbreak.

 

6. A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBIGDXISBDGGI
Date   Source Headline
14th May 201210:55 amRNSHolding(s) in Company
11th May 20123:15 pmRNSHolding(s) in Company
2nd May 20123:48 pmRNSTotal Voting Rights
1st May 20126:22 pmRNSTreasury Stock
2nd Apr 201210:20 amRNSTotal Voting Rights
1st Mar 201210:24 amRNSTotal Voting Rights
28th Feb 20127:00 amRNSChange of Adviser
23rd Feb 20122:15 pmRNSDirector/PDMR Shareholding
21st Feb 20123:08 pmRNSAdditional Listing
16th Feb 20127:00 amRNSInterim Management Statement
10th Feb 20129:38 amRNSTreasury Stock
9th Feb 201211:33 amRNSTreasury Stock
8th Feb 201210:32 amRNSTreasury Stock
3rd Feb 201212:22 pmRNSTreasury Stock
2nd Feb 20122:56 pmRNSTotal Voting Rights
24th Jan 20124:42 pmRNSBlocklisting Interim Review
3rd Jan 20124:57 pmRNSTotal Voting Rights
1st Dec 20114:40 pmRNSTotal Voting Rights
22nd Nov 20112:25 pmRNSDoc re. Half Year Report 2011/12
22nd Nov 20117:00 amRNSHalf Yearly Report
21st Nov 201111:08 amRNSDirector Declaration
14th Nov 20113:46 pmRNSHolding(s) in Company
14th Nov 20113:44 pmRNSNotice of Results
11th Nov 20117:00 amRNSDirectorate Change
2nd Nov 201112:56 pmRNSDirector Declaration
1st Nov 201111:12 amRNSTotal Voting Rights
17th Oct 20114:06 pmRNSHolding(s) in Company
11th Oct 20113:35 pmRNSHolding(s) in Company
6th Oct 20112:54 pmRNSDirector/PDMR Shareholding
3rd Oct 201110:41 amRNSTotal Voting Rights
15th Sep 201112:47 pmRNSDirector/PDMR Shareholding
1st Sep 201112:47 pmRNSTotal Voting Rights
26th Aug 20112:32 pmRNSBlocklisting Interim Review
16th Aug 20115:19 pmRNSAnnual Information Update
12th Aug 20114:43 pmRNSShare transactions and Purchase of Own Shares
8th Aug 201112:48 pmRNSTreasury Stock
1st Aug 20112:40 pmRNSTotal Voting Rights
29th Jul 20112:10 pmRNSDirectorate Change
29th Jul 20111:20 pmRNSResult of AGM
28th Jul 20117:00 amRNSAGM Statement
12th Jul 201110:13 amRNSDirector/PDMR Shareholding
11th Jul 20119:25 amRNSAcquisition
1st Jul 201111:55 amRNSTotal Voting Rights
28th Jun 20114:06 pmRNSDirector/PDMR Shareholding
27th Jun 201112:45 pmRNSAnnual Financial Report
21st Jun 20117:00 amRNSFinal Results
14th Jun 20119:24 amRNSNotice of Results
2nd Jun 201111:51 amRNSTotal Voting Rights
10th May 20119:00 amRNSAcquisition
5th May 201112:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.